🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cutaneous Squamous Cell Carcinoma

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Atezolizumab, Stereotactic Body Radiation Therapy TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Cutaneous Squamous Cell Carcinoma Staging Study NCT05695222n/a2 sites📍 London📍 London Queen Mary University of London · Tests: This is not an interventional study Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence NCT06692556Phase 328 sites📍 Le Puy-en-Velay📍 Pierre-Bénite📍 Dijon Centre Leon Berard · Tests: Adjuvant radiotherapy Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma NCT07337161NA1 site📍 London David Palma · Tests: SBRT, Standard Radiation A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites📍 Maastricht📍 Amsterdam📍 Amsterdam The Netherlands Cancer Institute · Tests: Nivolumab, Ipilumimab TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Res… Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC NCT05741073n/a1 site📍 Brussels EuMelaReg gGmbH A Study of IDP-001 in Advanced or Metastatic Solid Tumors NCT07602842Phase 1, Phase 26 sites📍 Los Angeles📍 Sarasota📍 Indianapolis InduPro, Inc. · Tests: IDP-001 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites📍 Kingswood📍 Wollongong📍 Southport Radiopharm Theranostics, Ltd · Tests: 177Lu-RAD204 SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants NCT06177106NA1 site📍 Tucson University of Arizona · Tests: Solar Simulated Light ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Blood and Tissue Collection IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma NCT06567314Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ivonescimab Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors NCT06171750Phase 15 sites📍 Bethesda📍 Boston📍 Portland Ankyra Therapeutics, Inc · Tests: tolododekin alfa, Cemiplimab (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record R… A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites📍 Los Angeles📍 Denver📍 New Haven GV20 Therapeutics · Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®] Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer NCT06532279Phase 2153 sites📍 Gilbert📍 Peoria📍 Phoenix NRG Oncology · Tests: Best Practice, Biospecimen Collection, Cisplatin, Computed Tomography, Image Guided Radiation Therapy Ex Vivo Cutaneous SCC NCT07402616NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: ex vivo 3D ultrasonography Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites📍 Grenoble📍 Lyon Alpha Tau Medical LTD. · Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients NCT06615635NA11 sites📍 Gilbert📍 Phoenix📍 Phoenix Alpha Tau Medical LTD. · Tests: DaRT seeds Thermotherapy in Addition to SOC Palliative Radiotherapy NCT06659146NA2 sites📍 London📍 London King's College London · Tests: Superficial hyperthermia A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites📍 Sacramento📍 Celebration📍 Miami Marengo Therapeutics, Inc. · Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation NCT05059444n/a57 sites📍 Birmingham📍 Chandler📍 Hot Springs Guardant Health, Inc. · Tests: Guardant Reveal Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies NCT07682831NA1 site📍 Victor University of Rochester · Tests: Two photon microscopy imaging Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site📍 Angers University Hospital, Angers · Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) A Study of VET3-TGI in Patients With Solid Tumors NCT06444815Phase 17 sites📍 Los Angeles📍 Orange📍 Miami KaliVir Immunotherapeutics · Tests: VET3-TGI, Atezolizumab Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Non-Interventional Study Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes NCT07746258NA1 site📍 Badalona Germans Trias i Pujol Hospital · Tests: Lymphadenectomy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy